title: p14ARF and p16INK4A, two products of the same gene, are differently expressed in cervical intraepithelial neoplasia.
abstract: OBJECTIVE
  To study the expression patterns of two different tumor suppressor proteins p16INK4A and p14ARF in cervical lesions. Both proteins are encoded by the same INK4A/ARF gene on chromosome 9p21. The expression patterns of these two proteins, both playing a central role in the cell cycle, were analyzed in detail in CIN, carcinomas, and normal epithelium to test the hypothesis that p16INK4A positive cells also demonstrate p14ARF expression.
  
  
  METHODS
  Serial tissue sections of 9 CIN1 lesions, 10 CIN2 lesions, 12 CIN3 lesions, and 7 carcinomas were stained with monoclonal antibodies against p16INK4A and p14ARF. The short fragment polymerase chain reaction hybridization line probe assay was used to detect HPV.
  
  
  RESULTS
  Normal epithelium was negative for both proteins. Marked immunoreactivity (++) for p16INK4A and p14ARF was observed in 5/7 carcinomas, 10/12 CIN3, and 1/10 CIN2 lesions and 0/9 CIN1 lesions. Simultaneous expression (+ or ++) was found in 19/22 CIN2/3 and not in CIN1 lesions. The fraction of p16INK4A-stained cells increased with CIN-grade. Overexpression of p14ARF was observed in a subpopulation of p16INK4A positive cells, and exclusively found in lesions infected with high-risk HPV. In two CIN3 lesions with early stromal invasion, p14ARF positivity was mainly found in the invasive cells. In carcinomas, all cells showed p16INK4A expression, whereas p14ARF was limited to the peripheral cells of the invasive tumor nests and individual migrating tumor cells.
  
  
  CONCLUSIONS
  Overexpression of p14ARF is limited to a fraction of the p16INK4A-expressing cells and therefore it is likely that p14ARF- and p16INK4A expression are not induced by the same mechanisms. Before expression of p14ARF can be linked to invasion or invasive phenotype, larger series of (micro-) invasive squamous lesions need to be studied.
authors.affiliation: Department of Pathology, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands. H.Bulten@pathol.umcn.nl
authors.forename: Johan
authors.initials: J
authors.lastname: Bulten
authors.forename: Irene A M
authors.initials: IA
authors.lastname: van der Avoort
authors.forename: Willem J G
authors.initials: WJ
authors.lastname: Melchers
authors.forename: Leon F A G
authors.initials: LF
authors.lastname: Massuger
authors.forename: Johanna M M
authors.initials: JM
authors.lastname: Grefte
authors.forename: Antonius G J M
authors.initials: AG
authors.lastname: Hanselaar
authors.forename: Peter C M
authors.initials: PC
authors.lastname: de Wilde
mesh_terms: D019941:Cyclin-Dependent Kinase Inhibitor p16 / Q000096:biosynthesis* / Q000235:genetics; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D027383:Papillomaviridae; D030361:Papillomavirus Infections / Q000235:genetics / Q000378:metabolism; D025803:Tumor Suppressor Protein p14ARF / Q000096:biosynthesis* / Q000235:genetics; D002583:Uterine Cervical Neoplasms / Q000235:genetics / Q000378:metabolism* / Q000473:pathology / Q000821:virology; D002578:Uterine Cervical Dysplasia / Q000235:genetics / Q000378:metabolism* / Q000473:pathology / Q000821:virology
chemical_list: D019941:Cyclin-Dependent Kinase Inhibitor p16; D025803:Tumor Suppressor Protein p14ARF